Scientists in the UK and Germany have developed and tested new compounds that enhance the contrast of magnetic resonance imaging (MRI) scans of the brain to show the location of receptor molecules linked to serious neurological disorders in real time. In research published in Chemical Scien ... more
Moving the MRI goalposts
Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly.
Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can overlap with MRI probe signals.
Now, David Parker and his team at the University of Durham have developed new probes, comprised of lanthanide complexes containing a t-butyl group, that shift the spectral window of MRI scans well away from these interfering signals. Parker describes this concept as “moving the goalposts.”
He said: “In any NMR experiment you are chasing sensitivity. We have enhanced the intrinsic ability to observe an MRI probe signal by a factor of 20.”
The distance between the lanthanide and the t-butyl group in the probes is fixed to optimise the rate of decay of the t-butyl signal, as well as its chemical shift. Using the new probes, the researchers were able to acquire data just a few minutes after administering them. They showed that the signal from the lanthanide-induced relaxation of the nine protons in the t-butyl group was shifted by up to 80ppm.
Parker says the new probes could lead to the development of new imaging experiments where the probes can be localised for defined periods of time in particular regions of the body.
- lanthanide complexes
- magnetic resonance imaging
- chemical shift
- Durham University
Scientists are set for a cash boost to develop the latest cancer imaging technologies. Cancer experts at Durham and Newcastle universities will receive more than £2 million over the next five years. The money is part of a £50 million nationwide initiative to establish the UK as a world le ... more
Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease. Research into Alzheimer’s disease has shown that the self-aggregation o ... more
Scientists in China have developed a simple microchip that enables quick and inexpensive high-throughput screening of potential drug candidates in 3D cell cultures. Scientists often use cell-based high-throughput screening in the first stage of drug design as a technique to quickly identify ... more
Scientists in Canada have developed a low-cost, portable, paper-based device for detecting antibiotic-resistant bacteria that could be used in the field in remote areas to characterise infectious diseases and assess food and water quality. The scientists used a paper support to hold wax-pat ... more